Joinn profits slide as lab monkey build-up backfires 大舉投資實驗猴失利 昭衍新藥盈利大倒退
The leading provider of pre-clinical drug research has predicted its first-half profits will plummet between 70% and 80% due to the falling value of its lab animals 受累于持有的生物資產市價下跌，這家CRO龍頭預告上半年盈利銳減七至八成。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.